IndraLab

Statements


OTUD7B inhibits LCL161-induced lung cancer cell invasion. 2 / 2
| 2

eidos
"Furthermore , OTUD7B can inhibit LCL161-induced lung cancer cell invasion and migration by deubiquitinating TRAF3 , inhibiting NIK and preventing non-canonical NF-kappaB activation ."

eidos
"Consistently , OTUD7B ( WT ) but not OTUD7B ( CH ) inhibited activation of the non-canonical NF-kappaB pathway and LCL161-induced lung cancer cell invasion and migration ( Fig. 9 ) ."